These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16297618)

  • 1. Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.
    Shi Q; Ornstein PL; Briner K; Richardson TI; Arnold MB; Backer RT; Buckmaster JL; Canada EJ; Doecke CW; Hertel LW; Honigschmidt N; Hsiung HM; Husain S; Kuklish SL; Martinelli MJ; Mullaney JT; O'Brien TP; Reinhard MR; Rothhaar R; Shah J; Wu Z; Xie C; Zgombick JM; Fisher MJ
    Bioorg Med Chem Lett; 2006 May; 16(9):2341-6. PubMed ID: 16297618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Tic-D-Phe Psi[CH2-CH2] isostere and its use in the development of melanocortin receptor agonists.
    Tian X; Chen X; Gan L; Hayes JC; Switzer AG; Solinsky MG; Ebetino FH; Wos JA; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1721-5. PubMed ID: 16376076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.
    Richardson TI; Ornstein PL; Briner K; Fisher MJ; Backer RT; Biggers CK; Clay MP; Emmerson PJ; Hertel LW; Hsiung HM; Husain S; Kahl SD; Lee JA; Lindstrom TD; Martinelli MJ; Mayer JP; Mullaney JT; O'Brien TP; Pawlak JM; Revell KD; Shah J; Zgombick JM; Herr RJ; Melekhov A; Sampson PB; King CH
    J Med Chem; 2004 Jan; 47(3):744-55. PubMed ID: 14736255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Privileged structure based ligands for melanocortin-4 receptors--aliphatic piperazine derivatives.
    Briner K; Collado I; Fisher MJ; García-Paredes C; Husain S; Kuklish SL; Mateo AI; O'Brien TP; Ornstein PL; Zgombick J; de Frutos O
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3449-53. PubMed ID: 16650763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and SAR studies on a series of 2-pyridinylpiperazines as potent antagonists of the melanocortin-4 receptor.
    Tran JA; Pontillo J; Fleck BA; Marinkovic D; Arellano M; Tucci FC; Lanier M; Saunders J; Jiang W; Chen CW; Foster AC; Chen C
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3693-6. PubMed ID: 16697187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of trans-4-(4-chlorophenyl)pyrrolidine-3-carboxamides of piperazinecyclohexanes as ligands for the melanocortin-4 receptor.
    Chen CW; Tran JA; Fleck BA; Tucci FC; Jiang W; Chen C
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6825-31. PubMed ID: 17964151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.
    Marinkovic D; Tucci FC; Tran JA; Fleck BA; Wen J; Chen C
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4817-22. PubMed ID: 18682322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach.
    Tian X; Field TB; Switzer AG; Mazur AW; Ebetino FH; Wos JA; Berberich SM; Jayasinghe LR; Obringer CM; Dowty ME; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
    J Med Chem; 2006 Jul; 49(15):4745-61. PubMed ID: 16854081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.
    Hong Q; Bakshi RK; Dellureficio J; He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Tang R; Kalyani RN; Macneil T; Vongs A; Rosenblum CI; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen D; Martin WJ; Chen AS; Metzger JM; Chen HY; Strack AM; Fong TM; Maclntyre E; Van der Ploeg LH; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4483-6. PubMed ID: 20598533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators.
    Guo L; Ye Z; Ujjainwalla F; Sings HL; Sebhat IK; Huber J; Weinberg DH; Tang R; MacNeil T; Tamvakopoulos C; Peng Q; MacIntyre E; van der Ploeg LH; Goulet MT; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3242-7. PubMed ID: 18479920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors.
    Gealageas R; Schneider S; Humbert JP; Bertin I; Schmitt M; Laboureyras E; Dugave C; Mollereau C; Simonnet G; Bourguignon JJ; Simonin F; Bihel F
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7471-4. PubMed ID: 23131340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propionylpiperazines as human melanocortin-4 receptor ligands.
    Chen CW; Tran JA; Jiang W; Tucci FC; Arellano M; Wen J; Fleck BA; Marinkovic D; White NS; Pontillo J; Saunders J; Madan A; Foster AC; Chen C
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4800-3. PubMed ID: 16824757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.
    Tomita K; Oishi S; Ohno H; Peiper SC; Fujii N
    J Med Chem; 2008 Dec; 51(23):7645-9. PubMed ID: 19007202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; Arellano M; Fleck BA; Huntley R; Marinkovic D; Lanier M; Nelson J; Parker J; Saunders J; Tucci FC; Jiang W; Chen CW; White NS; Foster AC; Chen C
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4417-23. PubMed ID: 15357964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of tetrahydrothiophenes and tetrahydrofurans and studies of their derivatives as melanocortin-4 receptor ligands.
    Tran JA; Chen CW; Tucci FC; Jiang W; Fleck BA; Chen C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1124-30. PubMed ID: 18082401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship studies on a series of cyclohexylpiperazines bearing a phanylacetamide as ligands of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; White NS; Arellano M; Fleck BA; Marinkovic D; Tucci FC; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5237-40. PubMed ID: 16183282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists.
    Tian X; Mishra RK; Switzer AG; Hu XE; Kim N; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Farmer JA; Sheldon RJ
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4668-73. PubMed ID: 16766182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines.
    Tucci FC; White NS; Markison S; Joppa M; Tran JA; Fleck BA; Madan A; Dyck BP; Parker J; Pontillo J; Arellano LM; Marinkovic D; Jiang W; Chen CW; Gogas KR; Goodfellow VS; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4389-95. PubMed ID: 16098742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor.
    Nozawa D; Okubo T; Ishii T; Kakinuma H; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2007 Mar; 15(5):1989-2005. PubMed ID: 17234422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.